Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-12-13FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental abbreviated new drug application for duloxetine hydrochloride from Aurobindo Pharma Limited (ANDA 090778), e…
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Long-term OL Study of [S,S]-RBX in Patients With Fibromyalgia [Phase 3]
Phase 3 long-term study of S,S-RBX in fibromyalgia was terminated.
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia. [Phase 3]
A Phase 3 multicenter trial evaluating S,S-Reboxetine in patients with fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-04Clinical Trial Update: Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+ [Phase 3]
A Phase 3 randomized trial evaluated duloxetine for fibromyalgia in patients with HIV-1 infection; the study is completed.
-
FDA approval · 2019-11-29FDA Approved: PREGABALIN — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original ANDA for pregabalin from Sun Pharmaceutical Industries, authorizing a generic version of pregabalin.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2019-11-04Clinical Trial Update: A Study for Adolescents With Fibromyalgia Syndrome [Phase 4]
A Phase 4 clinical trial in adolescents with fibromyalgia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Fibromyalgia Activity Study With Transcutaneous Electrical Nerve Stimulation (FAST) [NA]
A completed clinical trial investigating transcutaneous electrical nerve stimulation (TENS) for fibromyalgia has posted results.
-
FDA approval · 2019-10-08FDA Approved: PREGABALIN — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original Abbreviated New Drug Application for pregabalin, a generic version of the brand product.
-
CLINICAL_TRIALS trial_result · 2019-09-24Clinical Trial Update: Effect of Milnacipran on Pain in Fibromyalgia [Phase 4]
Phase 4 clinical trial evaluating milnacipran for pain in fibromyalgia has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Making Better Lives: Patient-Focused Care for Low Back Pain (LBP) [NA]
A completed clinical trial sponsored by the VA exploring patient-focused care for chronic low back pain and related conditions, with results…
-
FDA approval · 2019-08-16FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Yaopharma Co., Ltd.)
FDA approved the original application for duloxetine hydrochloride from Yaopharma Co., Ltd., granting approval for the generic product to be…
-
CLINICAL_TRIALS withdrawal · 2019-08-09Clinical Trial Update: Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed [Phase 4]
A Phase 4 trial investigating Cymbalta (duloxetine) for fibromyalgia pain was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-07-19Clinical Trial Update: Cefaly® Device in the Treatment of Patients With Fibromyalgia. [NA]
Clinical trial update for the Cefaly neurostimulation device in fibromyalgia has completed with results posted in 2019.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Cipla USA, Inc.)
FDA approves Cipla USA, Inc.'s original application for pregabalin, granting a generic version of the drug for its established indications.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen Pharmaceuticals' original application for pregabalin (generic pregabalin), enabling the generic product to be marketed …
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (AvPAK)
FDA approved AvPAK's original application for pregabalin, enabling the generic version to enter the market.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for pregabalin (generic) submitted by Rising Pharma Holdings, Inc., authorizing its market authorizati…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' generic pregabalin under ANDA207623 (original application), providing a generic version of pregabalin.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' original ANDA for pregabalin, enabling a generic version of pregabalin to be marketed. The approva…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for pregabalin, a generic version of Lyrica, for use in the United States. Th…
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Combined Behavioral and Analgesic Trial for Fibromyalgia [Phase 3]
Phase 3 trial update for a combined behavioral and analgesic treatment in fibromyalgia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: Development of a Mobile Application to Promote Self-care in Patients With Fibromyalgia [NA]
A completed clinical trial evaluating a mobile application to promote self-care in patients with fibromyalgia; results posted in 2019.
-
FDA approval · 2019-05-23FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Div of Pfizer Inc, indicating an approved modificat…
-
FDA approval · 2019-05-22FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for a generic duloxetine from Zydus Lifesciences Limited, authorizing marketing of the product.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia [Phase 2]
Phase 2 trial assessing safety and efficacy of milnacipran in pediatric patients with primary fibromyalgia; study terminated with posted res…